Pesquisa Odontológica Brasileira · 2003 · 41 citations · 16 references
Life SciencesInfectious DiseasesMicrobiologyMedical MicrobiologyOral MicrobiologyPediatric Infectious DiseasesAntifungal AgentsAntifungal ResistanceAntifungal TherapyFungal InfectionsOral Fungal MicrobiologyOral Microbial PathogenesisCandida Albicans InfectionChild Oral InfectionFungal Oral InfectionsPathogenicity AssaysPathogenicity AssessmentPathogenicity DeterminantsSelectivityYeast Pathogenicity
The oral fungal microbiota of 30 children with AIDS, of both genders, aged from two to six years, receiving outpatient treatment, was evaluated and compared with that of a control group composed of 30 healthy subjects with matching ages and genders. Virulence factors, such as exoenzyme production, and susceptibility to five antifungal agents using an E-Test kit were evaluated. C. albicans predominated over other species in the AIDS group, showing a higher production of proteinase and phospholipase when compared with that observed in the control group. In this study few clinical manifestations of and low selectivity for C. albicans (23.3%) were observed in the AIDS group. The enzymatic studies showed that 53.8% of the AIDS strains were strongly positive whereas only 33.3% of the non-AIDS strains were positive. Amphotericin B was the most effective drug among the antifungal agents tested against C. albicans. The frequency, selectivity and level of exoenzyme production by C. albicans suggest a higher pathogenicity in the AIDS children than in the control children.
16
Immune Deficiency Syndrome in Children
James M. Oleske · JAMA · 1983 · 477 citations
Prognostic factors and survival in children with perinatal HIV-1 infection
Pier‐Angelo Tovo, C. Gabiano, Emanuele Palomba et al. · The Lancet · 1992 · 357 citations
Manual of Clinical Microbiology
John D. Hare · Archives of Pediatrics and Adolescent Medicine · 1975 · 324 citations